BAC vs LEXXW · P/E 13, rev $31.56B vs rev $705.9K
Bank of America Corp (BAC) versus Lexaria Bioscience Corp (LEXXW) — a side-by-side from cached financials, not a winner call.
Bank of America Corp (BAC) is a banks - diversified company listed on US. It is led by Brian Thomas Moynihan.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
Latest reported BAC revenue for 2026-06-30 was $31.56B. Net income was $9.07B. Revenue was up 4.2% from 2026-03-31 to 2026-06-30. BAC currently screens at market cap $382.01B and trailing P/E 13.4.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
BAC currently screens at market cap $382.01B and trailing P/E 13.4. LEXXW currently screens at market cap $33.8M.
Not investment advice. Open the BAC and LEXXW stock pages for the full models.
Not investment advice.